In VSMCs, adiponectin promotes a contractile phenotype by binding to the adiponectin receptors R1 and R2 and T-cadherin, suggesting that adiponectin may protect from atherosclerosis. The gene discussed is ADIPOQ; the disease is atherosclerosis.